News
The spinout, dubbed Antares Therapeutics, will be fueled by a $177 million series A round co-led by Omega Funds, Atlas ...
Five months after selling a cancer drug to Lilly for up to $2.5 billion, Scorpion has debuted a successor company led by its ...
1d
Pharmaceutical Technology on MSNAntares Therapeutics gains $177m for cancer medicines developmentAdditional support came from Abingworth, Invus, Tenmile, Vida Ventures, Vinyanshu Ventures and Willett Advisors.
Antares Therapeutics, Inc. ("Antares"), a biotechnology company developing first-in-class precision medicines for cancer and ...
The rest of Scorpion’s assets were to be spun out into a new company. That startup, Boston-based Antares Therapeutics, launched Tuesday. Scorpion was founded in 2020 by serial biotech ...
Antares is a red supergiant star located 400 light-years from Earth. The waxing gibbous moon will shine close to the red star ...
Boston, USA-based biotech Antares Therapeutics, launched yesterday with $177 million in Series A financing. Antares is a spin ...
2d
Astronomy on MSNThe Sky Today on Tuesday, June 10: The Moon meets AntaresThe Moon passes 0.3° south of Antares at 7 A.M. EDT. You can catch them early this morning, when they are highest in the south just after midnight on the 9th. The Moon's bright light dominates the ...
Antares Therapeutics spun off of Scorpion Therapeutics, a clinical-stage biotech that Eli Lilly acquired earlier this year. Like Scorpion, Antares is developing small molecules that go after ...
The Scorpion Therapeutics spinoff sold rights for two EGFR inhibitors to Pierre Fabre Laboratories and is hoping to become a clinical-stage firm by 2026.
June's full moon, also known as the rare strawberry moon will appear tonight next to the bright red 'heart of the Scorpion' star, Antares in the constellation Scorpius during a Major Lunar Standstill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results